These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 32495921)

  • 1. An update on novel COVID-19 pandemic: a battle between humans and virus.
    Prajapati S; Sharma M; Kumar A; Gupta P; Narasimha Kumar GV
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5819-5829. PubMed ID: 32495921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus.
    Xu P; Sun GD; Li ZZ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5797-5809. PubMed ID: 32495918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chloroquine as a possible treatment for COVID-19].
    Coumou J; de Vries PJ
    Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in SARS-CoV-2: a systematic review.
    Bai YX; Xu YH; Wang X; Sun C; Guo Y; Qiu S; Ma KW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9208-9215. PubMed ID: 32965016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Disease 2019: Clinical Review.
    Gouveia CC; Campos L
    Acta Med Port; 2020 Jul; 33(7-8):505-511. PubMed ID: 32498762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA; Rezai S; Cleland E; Henderson CE
    Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding of COVID-19 based on current evidence.
    Sun P; Lu X; Xu C; Sun W; Pan B
    J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 14. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicines for the Treatment Of COVID-19: Awaiting the Evidence.
    Marto N; Monteiro EC
    Acta Med Port; 2020 Jul; 33(7-8):500-504. PubMed ID: 32425152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 in Children: Clinical Approach and Management.
    Sankar J; Dhochak N; Kabra SK; Lodha R
    Indian J Pediatr; 2020 Jun; 87(6):433-442. PubMed ID: 32338347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].
    Estella Á; Garnacho-Montero J
    Med Intensiva (Engl Ed); 2020 Nov; 44(8):509-512. PubMed ID: 32423569
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E
    Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Remdesivir, the antiviral hope against SARS-CoV-2].
    Reina J
    Rev Esp Quimioter; 2020 Jun; 33(3):176-179. PubMed ID: 32239125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.